Cancer Genetics and Precision Cancer Therapy - Life Sciences Forum
Δημοσιεύτηκε στις 9 Φεβ 2014
Please
join us as MITCNC hosts the second Bay Area with/in/sight lecture
series from the David H. Koch Institute for Integrative Cancer Research
at MIT. We invite you to enjoy the networking reception, mingle with
fellow guests and scientists, and join us for a series of informative
talks about recent exciting progress in the areas of cancer genetics and
new treatments based on our understanding of cancer genes.
The
event will showcase research from MIT's Dr. Tyler Jacks, PhD, David H.
Koch Professor of Biology, Investigator at the Howard Hughes Medical
Institute, and Director of the Koch Institute for Integrative Cancer
Research. Professor Jacks will discuss work from his laboratory on the
development of novel therapeutic strategies that target common genetic
alterations in many human cancers.
Dr. Jacks will be joined by
Dr. Kevin Shannon, MD, who is the Roma and Marvin Auerback Distinguished
Professor in Pediatric Oncology at the University of California, San
Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr.
Shannon, a physician-scientist, will discuss the challenges and
opportunities of new cancer medicines from a clinical perspective.
Rounding out the program will be Dr. Jeffrey Settleman, PhD. Dr.
Settleman is Senior Director of Discovery Oncology at Genentech. He will
present research from his own laboratory at Genentech as well as review
new cancer therapeutic programs at the company. The panel discussion
will be moderated by Dr. Laura D. Attardi, PhD, an Associate Professor
in the Departments of Radiation Oncology & Genetics, at Stanford
University School of Medicine.
join us as MITCNC hosts the second Bay Area with/in/sight lecture
series from the David H. Koch Institute for Integrative Cancer Research
at MIT. We invite you to enjoy the networking reception, mingle with
fellow guests and scientists, and join us for a series of informative
talks about recent exciting progress in the areas of cancer genetics and
new treatments based on our understanding of cancer genes.
The
event will showcase research from MIT's Dr. Tyler Jacks, PhD, David H.
Koch Professor of Biology, Investigator at the Howard Hughes Medical
Institute, and Director of the Koch Institute for Integrative Cancer
Research. Professor Jacks will discuss work from his laboratory on the
development of novel therapeutic strategies that target common genetic
alterations in many human cancers.
Dr. Jacks will be joined by
Dr. Kevin Shannon, MD, who is the Roma and Marvin Auerback Distinguished
Professor in Pediatric Oncology at the University of California, San
Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr.
Shannon, a physician-scientist, will discuss the challenges and
opportunities of new cancer medicines from a clinical perspective.
Rounding out the program will be Dr. Jeffrey Settleman, PhD. Dr.
Settleman is Senior Director of Discovery Oncology at Genentech. He will
present research from his own laboratory at Genentech as well as review
new cancer therapeutic programs at the company. The panel discussion
will be moderated by Dr. Laura D. Attardi, PhD, an Associate Professor
in the Departments of Radiation Oncology & Genetics, at Stanford
University School of Medicine.
Κατηγορία
Άδεια
- Τυπική άδεια YouTube
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου